Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Coeptis Therapeutics Holdings (COEP) Debt to Equity (2021 - 2025)

Historic Debt to Equity for Coeptis Therapeutics Holdings (COEP) over the last 5 years, with Q3 2025 value amounting to $0.01.

  • Coeptis Therapeutics Holdings' Debt to Equity fell 5436.0% to $0.01 in Q3 2025 from the same period last year, while for Sep 2025 it was $0.01, marking a year-over-year decrease of 5436.0%. This contributed to the annual value of $0.31 for FY2024, which is 6718.7% up from last year.
  • Coeptis Therapeutics Holdings' Debt to Equity amounted to $0.01 in Q3 2025, which was down 5436.0% from $0.02 recorded in Q2 2025.
  • Coeptis Therapeutics Holdings' 5-year Debt to Equity high stood at $0.7 for Q4 2021, and its period low was -$0.13 during Q1 2024.
  • For the 5-year period, Coeptis Therapeutics Holdings' Debt to Equity averaged around $0.12, with its median value being $0.08 (2023).
  • Its Debt to Equity has fluctuated over the past 5 years, first skyrocketed by 44711.62% in 2023, then tumbled by 17420.49% in 2024.
  • Quarter analysis of 5 years shows Coeptis Therapeutics Holdings' Debt to Equity stood at $0.7 in 2021, then tumbled by 95.2% to $0.03 in 2022, then skyrocketed by 447.12% to $0.18 in 2023, then soared by 67.19% to $0.31 in 2024, then crashed by 95.54% to $0.01 in 2025.
  • Its Debt to Equity stands at $0.01 for Q3 2025, versus $0.02 for Q2 2025 and $0.11 for Q1 2025.